Store
Hematology and Coagulation Markets, 2023
Publication Date: April 5, 2023
Tags: Coagulation, Diagnostic Instruments, Hematology, In Vitro Diagnostics (IVD)
Pages: 75
SKU: 23-708
Discover the lucrative $10 billion-dollar market for hematology and coagulation in vitro diagnostic (IVD) testing with Kalorama’s comprehensive report, Hematology and Coagulation Markets, 2023. This analysis delves into the dynamic growth factors driving this market, including new technologies, the aging population, and the increasing demand for decentralized testing.
Key Insights Provided:
- Market sizing for Hematology IVD and Coagulation IVD
- Markets for Decentralized and Lab-based Segments
- Forecasts to 2027
- Market Share
Country Markets Covered:
Explore individual country markets for Hematology (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Spain, Turkey, United Kingdom, United States) and Coagulation (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Spain, Turkey, United Kingdom, United States).
In-depth Analysis:
Hematology: Hematology testing plays a vital role in diagnosing blood-related diseases such as leukemias, anemia, and autoimmune disorders. The report covers essential tests like complete blood count (CBC) and its components, highlighting the industry’s shift towards automation and IT solutions.
Coagulation: The report explores the complexities of hemostasis (coagulation) and its role in regulating blood flow and clot formation. It discusses the increasing demand for reliable and efficient hemostasis testing solutions, particularly in managing anticoagulant therapies and preventing clot-related conditions.
Market Data:
All market data are based on factory sales to end-users, providing a direct insight into market size and dynamics. The report presents market segments in U.S. dollar values, reflecting the number of tests performed and the associated costs.
Stay Ahead of the Curve!
As the market for hematology and coagulation IVD testing continues to evolve, Kalorama’s report offers essential insights to help you navigate this dynamic landscape and capitalize on emerging opportunities. Order your copy today to unlock the full potential of this growing market.
Table: Coagulation Diagnostic Sales, by Test Category, 2022 ($ millions)
Test Category | 2022 $ | % Mkt |
D-dimer | $XX Million | XX% |
PT/INR Lab | $XX Million | XX% |
Thrombophilia SNP | $XX Million | XX% |
POC Coagulation | $XX Million | XX% |
Total | $XX Million | XX% |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
Chapter 1: Executive Summary
Hematology Market Overview
Hematology Market Sales
- Figure 1-1: Global Hematology Testing Market by Product Segment (Lab-based Hematology and Decentralized [POC] Hematology), 2022-2027 ($ million)
- Figure 1-2: Global Hematology Testing Market by Product Segment (Lab-based Hematology and Decentralized [POC] Hematology), 2022-2027 (% market)
Coagulation Market Overview
Coagulation Market Sales
- Figure 1-3: Coagulation Diagnostic Sales by Test Category, 2022 (D-dimer, PT/INR, Thrombophilia SNP, POC) ($ millions)
- Figure 1-4: Coagulation Diagnostic Sales by Test Category, 2022 (D-dimer, PT/INR, Thrombophilia SNP, POC) (%)
Recent Developments in Hematology and Coagulation
Developments
Scope and Methodology
Chapter 2: Focus on Hematology
Overview of Hematology
Market Outlook
- Figure 2-1: Global Hematology Testing Market by Product Segment (Lab-based Hematology and POC Hematology), 2022-2027 ($ million)
- Table 2-2: Lab-Based and Decentralized Hematology Market Summary
- Figure 2-2: Hematology Analyzer/Instrument FDA CLIA Amendments by Year, 2000-2022
- Figure 2-3: Hematology Analyzer/Instrument Market Share, by Top Vendor (Abbott, Beckman Coulter, Becton Dickinson, EKF, Horiba, Mindray, Roche, Siemens, Sysmex, Others), 2022 (%)
Chapter 3: Focus on Coagulation
Overview of Diagnostics in Coagulation
Market Outlook
- Table 3-1: Coagulation Diagnostic Sales by Test Category, 2022 (D-dimer, PT/INR, Thrombophilia SNP, POC) ($ millions)
- Figure 3-1: Coagulation Diagnostic Sales by Broad Test Category, 2017-2022 ($ millions)
Major Product Activity
PT/INR
Thrombophilia SNP
D-dimer
POC Coagulation
- Figure 3-2: POC Coagulation Testing Market Distribution (Professional, Home/Patient), 2022 (%)
Laboratory vs. Point-of-Care Markets
- Figure 3-3: Coagulation Testing Market by End Use Setting (Laboratory, Point-of-Care), 2017-2027
Chapter 4: International Regional Trends
Regional Hematology Market
- Table 4-1: Hematology Analyzer/Reagent Market by Region (North America, Europe, Asia Pacific, ROW), 2022-2027 ($ millions)
- Figure 4-1: Hematology Analyzer/Reagent Market by Setting and Region (Asia Pacific, Europe, North America, ROW), 2022-2027 ($ millions)
Regional Coagulation Market
- Table 4-2: Coagulation Diagnostic Test Sales Distribution by Global Region, 2022 (Asia Pacific, Europe, North America, ROW) (%)
Country-Level Hematology and Coagulation Market
- Figure 4-2: Global Market for Hematology, by Select Country (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Spain, Turkey, United Kingdom, United States), 2022-2027 ($ millions)
- Figure 4-3: Global Market for Coagulation PT/INR, by Select Country (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Spain, Turkey, United Kingdom, United States), 2022-2027 ($ millions)
Australia
- Table 4-3: Australia Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)
Brazil
- Table 4-4: Brazil Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)
Canada
- Table 4-5: Canada Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)
China
- Table 4-6: China Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)
France
- Table 4-7: France Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)
Germany
- Table 4-8: Germany Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)
India
- Table 4-9: India Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)
Italy
- Table 4-10: Italy Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)
Japan
- Table 4-11: Japan Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)
Spain
- Table 4-12: Spain Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)
Turkey
- Table 4-13: Turkey Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)
United Kingdom
- Table 4-14: United Kingdom Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)
United States
- Table 4-15: US Market for Hematology and Coagulation (Hematology, Coagulation PT/INR), 2022-2027 ($ millions) (%)
Chapter 5: Corporate Profiles
Top Hematology and Coagulation Company Briefs
Abbott Diagnostics
Hematology
Abingdon Health Ltd.
Beckman Coulter, Inc. / Danaher
Hematology
Hematology IT
Biotype Diagnostic GmbH
BioView Ltd.
CellaVision AB
Danaher
Diagnostica Stago S.A.S.
EKF Diagnostics Holdings Plc
ELITech Group S.A.S.
Grifols S.A.
Coagulation
Horiba Medical
Instrumentation Laboratory (IL) / Werfen
Coagulation
Mast Group
Menarini Diagnostics
Mindray – Shenzhen Mindray Bio-medical Electronics Co., Ltd.
Nihon Kohden
Nova Biomedical
Roche Diagnostics
Hematology
Coagulation
Sekisui Diagnostics LLC
Siemens Healthineers (Siemens)
Hematology
Streck Inc.
Sysmex Corporation
Hematology
Coagulation